BB Biotech AG (XSWX:BION) Treasury Stock: CHF-8.2 Mil (As of Mar. 2026)


XSWX:BION BB Biotech AG XSWX:BION
34 GF Score
Price CHF49.75
! 4 Warning Signs
View Full Analysis

What is BB Biotech AG Treasury Stock?

BB Biotech AG XSWX:BION +1.32% 34 Treasury Stock is CHF-8.2 Mil as of Mar. 2026. GuruFocus rates XSWX:BION with a GF Score™ of 34/100. The stock has 4 warning signs investors should review.

Treasury stock is the portion of shares that a company keeps in their own treasury. BB Biotech AG's treasury stock for the quarter that ended in Mar. 2026 was CHF-8.2 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

BB Biotech AG Treasury Stock Historical Data

* Premium members only.

The historical data trend for BB Biotech AG's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BB Biotech AG Treasury Stock Chart

BB Biotech AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Treasury Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.21 -36.51 -36.51 -39.64 -8.17

BB Biotech AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Treasury Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -42.06 -41.98 -8.17 -8.17 -8.17
XSWX:BION
34GF Score
BB Biotech AG XSWX:BION
Treasury Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BB Biotech AG Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Frequently Asked Questions Learn more about Treasury Stock →
What does a Treasury Stock of CHF-8.2 Mil mean?
BB Biotech AG (XSWX:BION) has a Treasury Stock of CHF-8.2 Mil as of Mar. 2026. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for BB Biotech AG and its competitors.
Is BB Biotech AG's Treasury Stock too high?
BB Biotech AG's current Treasury Stock is CHF-8.2 Mil. Overall, BB Biotech AG has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's Treasury Stock compare to VRTX and REGN?
BB Biotech AG's Treasury Stock of CHF-8.2 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Treasury Stock for a Biotechnology company?
A good Treasury Stock depends on the Biotechnology industry context. However, Treasury Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Treasury Stock mean?
A high Treasury Stock can signal that a stock is expensive relative to its fundamentals. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for BB Biotech AG and its competitors. BB Biotech AG's current Treasury Stock is CHF-8.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (XSWX:BION) has a current Treasury Stock of CHF-8.2 Mil. The current Treasury Stock is CHF-8.2 Mil. BB Biotech AG's overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Treasury Stock calculated?
Treasury Stock is calculated from a company's financial statements. For BB Biotech AG (XSWX:BION), the current Treasury Stock is CHF-8.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BB Biotech AG Business Description

Address Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
34GF Score

Get the complete analysis for XSWX:BION

Treasury Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF49.75
Price